Related references
Note: Only part of the references are listed.Effect of sodium-glucose cotransporter-2 inhibitors on cardiac remodelling: a systematic review and meta-analysis
Nan Zhang et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2022)
Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology
Alberto Aimo et al.
EUROPEAN JOURNAL OF HEART FAILURE (2022)
Impact of type 2 diabetes mellitus on left ventricular deformation in non-ischemic dilated cardiomyopathy patients assessed by cardiac magnetic resonance imaging
Meng-Ting Shen et al.
CARDIOVASCULAR DIABETOLOGY (2022)
Biology of myocardial recovery in advanced heart failure with long-term mechanical support
Eleni Tseliou et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2022)
Prognostic value of plasma big endothelin-1 in left ventricular non-compaction cardiomyopathy
Peng Fan et al.
HEART (2021)
Endothelin-1, cardiac morphology, and heart failure: the MESA angiogenesis study
Peter J. Leary et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2020)
Heart Failure With Recovered Left Ventricular Ejection Fraction JACC Scientific Expert Panel
Jane E. Wilcox et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Endothelial Forkhead Box Transcription Factor P1 Regulates Pathological Cardiac Remodeling Through Transforming Growth Factor-β1-Endothelin-1 Signal Pathway
Jie Liu et al.
CIRCULATION (2019)
Imaging, Biomarker, and Clinical Predictors of Cardiac Remodeling in Heart Failure With Reduced Ejection Fraction
Alberto Aimo et al.
JACC-HEART FAILURE (2019)
NT-proBNP Goal Achievement Is Associated With Significant Reverse Remodeling and Improved Clinical Outcomes in HFrEF
Melissa A. Daubert et al.
JACC-HEART FAILURE (2019)
Reverse remodelling and myocardial recovery in heart failure
Gene H. Kim et al.
NATURE REVIEWS CARDIOLOGY (2018)
The association between plasma big endothelin-1 levels at admission and long-term outcomes in patients with atrial fibrillation
Shuang Wu et al.
ATHEROSCLEROSIS (2018)
Physiologic, Pathologic, and Therapeutic Paracrine Modulation of Cardiac Excitation-Contraction Coupling
Joshua Mayourian et al.
CIRCULATION RESEARCH (2018)
Clinical Phenotype and Genotype Associations With Improvement in Left Ventricular Function in Dilated Cardiomyopathy
Job A. J. Verdonschot et al.
CIRCULATION-HEART FAILURE (2018)
Combined baseline and one-month changes in big endothelin-1 and brain natriuretic peptide plasma concentrations predict clinical outcomes in patients with left ventricular dysfunction after acute myocardial infarction: Insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) study
A. Olivier et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)
Plasma level of big endothelin-1 predicts the prognosis in patients with hypertrophic cardiomyopathy
Yilu Wang et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)
Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure
Lars Kober et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
The Prognostic Impact of the Evolution of RV Function in Idiopathic DCM
Marco Merlo et al.
JACC-CARDIOVASCULAR IMAGING (2016)
Biomarker-assist score for reverse remodeling prediction in heart failure: The ST2-R2 score
Josep Lupon et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2015)
Endothelin-1 critically influences cardiac function via superoxide-MMP9 cascade
Catherine K. Hathaway et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Head-to-Head Comparison of Serial Soluble ST2, Growth Differentiation Factor-15, and Highly-Sensitive Troponin T Measurements in Patients With Chronic Heart Failure
Hanna K. Gaggin et al.
JACC-HEART FAILURE (2014)
Quantitative Evaluation of Drug or Device Effects on Ventricular Remodeling as Predictors of Therapeutic Effects on Mortality in Patients With Heart Failure and Reduced Ejection Fraction A Meta-Analytic Approach
Daniel G. Kramer et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
The prognostic value of big endothelin-1 in more than 2,300 patients with heart failure enrolled in the Valsartan Heart Failure Trial (Val-HeFT)
Serge Masson et al.
JOURNAL OF CARDIAC FAILURE (2006)
Superiority of big endothelin-1 and endothelin-1 over natriuretic peptides in predicting survival in severe congestive heart failure:: A 7-year follow-up study
R van Beneden et al.
JOURNAL OF CARDIAC FAILURE (2004)
Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure
MR Bristow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)